IHS Chemical Week

Regions :: Southeast Asia

Lonza to Build Cell Therapy Production Facility in Singapore

12:19 AM MDT | May 19, 2009 | Deepti Ramesh

Lonza says it will build a new cell therapy manufacturing facility in Singapore to expand its global presence and to meet the growing worldwide demand for cell therapies. The facility will be located adjacent to Lonza’s large-scale mammalian manufacturing facility at Tuas Biomedical Park in Singapore. The first phase of the facility will involve an investment of SF30 million ($27 million). Construction of the facility will begin in early 2010 and it is expected to start manufacturing therapies in the first two suites by mid 2011. The facility will be...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa